Evidence map›Paper›PMID 32198479›Full record

ArticleScientific reports2020

Publisher Correction: Lyso-Gb3 modulates the gut microbiota and decreases butyrate production.

John-Jairo Aguilera-Correa, Patricia Madrazo-Clemente, María Del Carmen Martínez-Cuesta, Carmen Peláez, Alberto Ortiz, María Dolores Sánchez-Niño, Jaime Esteban, Teresa Requena

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

John-Jairo Aguilera-Correa *Clinical Microbiology Department, IIS-Fundación Jiménez Díaz, UAM. Av. Reyes Católicos, 2, 28040, Madrid, Spain. john_j2a@hotmail.com.ORCID http://orcid.org/0000-0002-4002-1944
Patricia Madrazo-ClementeClinical Microbiology Department, IIS-Fundación Jiménez Díaz, UAM. Av. Reyes Católicos, 2, 28040, Madrid, Spain.
María Del Carmen Martínez-CuestaDepartment of Food Biotechnology and Microbiology, Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM), Nicolás Cabrera, 9, 28049, Madrid, Spain.
Carmen PeláezDepartment of Food Biotechnology and Microbiology, Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM), Nicolás Cabrera, 9, 28049, Madrid, Spain.
Alberto OrtizNephrology Department. IIS-Fundación Jiménez Díaz, UAM. Av. Reyes Católicos, 2, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-9805-9523
María Dolores Sánchez-Niño *Nephrology Department. IIS-Fundación Jiménez Díaz, UAM. Av. Reyes Católicos, 2, 28040, Madrid, Spain.
Jaime Esteban *Clinical Microbiology Department, IIS-Fundación Jiménez Díaz, UAM. Av. Reyes Católicos, 2, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-8971-3167
Teresa Requena *Department of Food Biotechnology and Microbiology, Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM), Nicolás Cabrera, 9, 28049, Madrid, Spain.
Hospital Universitario Fundación Jiménez Díaz · ESInstituto de Investigación en Ciencias de la Alimentación · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32198479
PMCPMC7083834
OpenAlexW3010901101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.